CBG CBD Gummies Market : Global Industry Analysis 2016 - 2025 and Opportunity Assessment 2026 - 2036

CBG CBD Gummies Market Size, Market Forecast and Outlook By FMI

The CBG CBD gummies market is expected to grow from USD 189.5 million in 2025 to USD 585.5 million by 2036, at a 10.8% CAGR, driven by minor cannabinoid blend launches and rising interest in daytime wellness formats, with hemp-derived formats accounting for 83.6% share and CBD-rich CBG blend gummies contributing 61.8% share as companies prioritize compliant labeling and repeat-use product trust.

Summary of CBG CBD Gummies Market

• Demand Drivers
  • CBG CBD gummies are gaining attention as brands move beyond plain CBD formats and explain blends in simple wellness terms.
  • Daytime calm and focus use cases are helping CBG stand apart from sleep-focused CBD gummy products.
  • Retailers prefer products with clear labels and test records because edible cannabinoid products need careful review.
• Product and Segment View
  • Hemp-derived gummies are expected to keep stronger retailer acceptance because source records are easier to check.
  • CBD-rich CBG blends are likely to stay more familiar for new users who already understand CBD.
  • Standard dose gummies fit daily routines better than high-dose products because buyers want a simple starting point.
• Geography and Competitive Outlook
  • United States has broader online retail activity for CBG CBD gummies due to strong hemp wellness channels.
  • Canada offers a more controlled route through licensed edible retail and regulated product checks.
  • European and Australian sellers need stronger product files because cannabinoid edible rules are more cautious.
• Analyst Opinion
  • Nandini Roy Choudhury, Principal Consultant for Food and Beverage at FMI, observes, “CBG CBD gummies are moving beyond basic CBD edibles into blend-specific wellness formats. Buyers compare cannabinoid ratios and third-party testing before repeat purchase. Claim discipline now affects shelf access. Suppliers pairing clean source records with simple benefit wording should defend stronger shelf and online positions.”
• CBG CBD Gummies Market Value Analysis
  • The CBG CBD gummies market is moving from basic CBD edible demand into a more defined cannabinoid blend space.
  • Adoption is being driven by shoppers who want simple daytime calm and focus products.
  • The market is also benefiting from brands that explain CBG through familiar CBD gummy formats.
  • Demand is further supported by the need for clear dose labels with clean source records and product files that help retailers trust edible cannabinoid products.

Regulatory uncertainty remains the defining operating pressure for CBD gummies as brands expand consumer access without a fully established federal framework. In March 2026, the U.S. FDA advanced a Cannabidiol Products Compliance and Enforcement Policy for White House review, signalling movement toward a more structured approach after years of case-by-case oversight. The development gives manufacturers stronger incentives to invest in compliant labeling and quality systems rather than relying on regulatory ambiguity. Enforcement activity is also shaping commercialization strategies. The FDA continues to issue warning letters against cannabis-derived products carrying unapproved therapeutic claims which is pushing suppliers toward wellness positioning supported by disciplined marketing practices. At the same time, product innovation remains active as companies broaden gummy portfolios to address differentiated consumer occasions and preferences rather than competing solely on cannabidiol concentration. The combination of emerging regulatory direction and targeted portfolio expansion is shifting the market toward brands that prioritize compliance readiness alongside repeat consumer engagement.

CBG CBD Gummies Market Definition

CBG CBD gummies are edible wellness products made with cannabigerol and cannabidiol in a chewable gummy format. The market is built around consumers who want a simple way to try minor cannabinoid blends without using oils or capsules. CBG gives brands a route to explain daytime calm and focus positioning, while CBD keeps the product familiar for buyers who already understand hemp-based wellness products.

CBG CBD Gummies Market Inclusions

Market scope covers CBG CBD gummy products categorized by cannabinoid blend, including CBD-rich CBG blend and balanced blend formats. CBG-rich blend, broad-spectrum blend, and isolate blend formats are included only when both CBG and CBD are present in the finished gummy. Dose range covers low dose, standard dose, and high dose products sold through legal retail channels. Wellness positioning covers daytime calm, focus support, sleep support, recovery support, and general wellness. Sales channel coverage includes online specialty retail, dispensary retail, pharmacy access, wellness stores, and direct brand sites. Source status includes hemp-derived and cannabis-derived formats where local rules permit commercial sale. Revenue scope covers 2026 to 2036. The key stakeholders include CBG CBD gummy brands, hemp extract suppliers, cannabinoid formulators, gummy manufacturers, licensed cannabis retailers, online CBD stores, pharmacy access operators, wellness retailers, testing labs, regulatory bodies, and packaging suppliers.

CBG CBD Gummies Market Exclusions

Scope excludes THC-heavy gummies and medical cannabis prescriptions. Beverages and capsules are outside scope. Oils and single-CBD gummies without CBG are excluded. ASEAN CBD gummies are excluded unless products are legal and commercially sold. Saudi Arabia and GCC countries are excluded from demand positioning due to cannabis-derived product risk. General confectionery and hemp milk are outside revenue scope.

CBG CBD Gummies Market Research Methodology

• Primary Research: Future Market Insights analysts reviewed official product catalogs, cannabinoid certificates, dose declarations, retailer listings, and brand-owned product pages from active CBG CBD gummy suppliers.
• Desk Research: Public information from the United States Food and Drug Administration, Federal Trade Commission, United States Department of Agriculture National Agricultural Statistics Service, Health Canada, Food Standards Agency, European Food Safety Authority, and Therapeutic Goods Administration was reviewed.
• Company Source Review: Official company information from Charlotte’s Web Holdings Inc., Medterra CBD LLC, Extract Labs, CBDfx, Joy Organics, Neurogan, Koi CBD, Tilray Brands Inc., Nordic Oil GmbH, and Cibdol was checked for active product presence and channel relevance.
• Market Sizing and Forecasting: Estimated using a bottom-up product-boundary approach. Eligible stock keeping unit revenue, channel presence, retail pricing, product positioning, and country-level adoption were used to construct the 2026 market estimate.
• Data Validation: Forecast checks compared legal retail access, hemp-derived product availability, edible cannabinoid rules, brand product files, and country-level channel readiness. Products outside legal consumer channels were excluded from revenue estimates.

Why is the CBG CBD Gummies Market Growing?

• Minor cannabinoid blends give brands a clear route to explain CBG inside familiar CBD gummy formats.
• Online retail supports education-based selling through dose pages and certificate access.
• Regulatory review pushes brands toward careful wording, which makes tested products easier for retailers to trust.

CBG CBD gummy demand is supported by a shift from plain CBD formats toward blend-specific daily wellness products. DoorDash expanded hemp-derived THC and CBD product ordering in select U.S. states in January 2025. The company said eligible users could order gummies and other hemp-derived products through the app with electronic ID checks. Brands can learn from mushroom-based snacks by using simple benefit wording and familiar gummy formats. Stronger suppliers will keep product pages focused on dose and testing proof.

Market Segmentation Analysis

• Hemp-derived products are expected to hold 83.6% share in 2026 due to low-THC source records and wider retailer acceptance.
• Familiar CBD wording lowers consumer trial risk, so CBD-rich CBG blend formats are forecast to account for 61.8% share in 2026.
• Online specialty retail should secure 52.3% share in 2026 through certificate access and blend comparison.
• Daily wellness routines support standard dose products, which are expected to represent 48.7% share in 2026.
• Daytime calm positioning is forecast at 34.6% share in 2026 as CBG pairing gives brands a route beyond sleep-heavy shelves.

The market is divided into five primary segment groups based on product spectrum and dose band. Wellness position, sales channel and buyer type complete the structure. Product spectrum covers broad spectrum CBD gummies and CBD isolate gummies. Full spectrum CBD gummies, synthetic CBD and minor blends complete the product scope. Dose band covers 2.5 mg and 5 mg formats. 10 mg, variable dose and mini chews complete the dose scope. Wellness position covers calm support and sleep entry. Daily balance, recovery light and focus support complete the wellness scope. Sales channel covers brand websites and specialist retail. Cannabis retail, pharmacy retail and private label complete the channel scope. Buyer type covers first-time users and THC avoiders. Routine users, wellness switchers and sensitive users complete the buyer scope.

Insights into CBG CBD Gummies Market by Cannabinoid Blend

• CBD-rich CBG blend is forecast to account for 61.8% share in 2026. Familiar CBD wording helps buyers understand CBG without needing long product education.
• Balanced blend formats are projected to appeal to repeat buyers who want equal product focus on CBD and CBG. This format suits brands that explain ratio and serving size clearly.

Insights into CBG CBD Gummies Market by Sales Channel

• Online specialty retail is expected to secure 52.3% share in 2026. Product pages let shoppers check dose strength and lab records before ordering.
• Dispensary retail keeps value in licensed channels because staff can explain cannabinoid blends at the counter. Brand-owned websites can support the same learning path for cbd gummies.

Insights into CBG CBD Gummies Market by Dose Range

• Standard dose formats are forecast to represent 48.7% share in 2026. Moderate serving sizes make repeat use easier for daily wellness buyers.
• Low dose gummies support cautious first-time users who want a softer entry point. This gives brands room to build trust before consumers move to stronger blends.

Insights into CBG CBD Gummies Market by Wellness Positioning

• Daytime calm positioning is expected to capture 34.6% share in 2026. CBG pairing gives brands a clearer position beyond sleep-focused CBD shelves.
• Focus support products need careful wording because cannabinoid claims face close review. Product education can borrow simple format learning from coQ10 gummies.

Insights into CBG CBD Gummies Market by Source Status

• Hemp-derived formats are expected to hold 83.6% share in 2026. Low-THC source records help brands clear retailer checks with less friction.
• Cannabis-derived variants keep a role in licensed channels that already manage edible cannabinoid products. Hemp-derived formats fit wellness retail better when backed by cbd oil style documentation.

CBG CBD Gummies Market Drivers, Restraints, and Opportunities

• Driver: Blend-based wellness positioning is turning CBG CBD gummies into a repeat-use format for calm and focus routines.
• Restraint: Snack-like edible packaging can create legal risk for cannabinoid gummy brands.
• Opportunity: Clear dose labels and test records can support premium positions for compliant hemp-derived gummies.

Demand is shifting toward better explained cannabinoid gummy formats. cbdMD listed THCV+CBG Energy Softgels in January 2024 as part of its minor cannabinoid product activity. The product is not a gummy, so use it only to support broader CBG wellness positioning. The launch supports the shift from generic CBD gummies toward blend-specific products with a clearer use case. FTC and FDA sent letters to five firms in July 2024 over delta-8 THC edibles using packaging close to common snacks. That action makes adult-oriented design and careful benefit wording more important for CBG CBD gummy suppliers.

Raw Material Price and Formulation Cost Analysis

CBG CBD gummy pricing depends on hemp flower supply and cannabinoid extraction cost. USDA NASS reported 2025 U.S. floral hemp production grown in the open at 33.2 million pounds. Wider floral hemp supply can improve extract access, but CBG-rich input still needs targeted hemp genetics and careful processing. Suppliers using CBD oil product documentation can manage quality checks better across edible formats. Formulators compare cannabinoid ratio and dose cost before fixing gummy price points.

Consumer Segmentation and Purchase Behavior Analysis

Consumers are choosing CBG CBD gummies based on dose clarity and simple wellness wording. Health Canada’s 2024 cannabis survey reported that edibles were consumed by 55.0% of people who consumed cannabis in the past twelve months. Edible familiarity supports gummy trial, while cautious buyers still need clear cannabinoid labels. Shoppers moving from jellies and gummies into cannabinoid formats expect familiar texture and controlled serving sizes. Repeat buyers are more likely to compare CBD and CBG ratios before selecting a brand.

Analysis of CBG CBD Gummies Market by Key Countries and Regions

Country or Region	CAGR
United States	12.2%
Canada	11.4%
United Kingdom	9.7%
European Union	8.8%
Australia	7.9%

Source: Future Market Insights, 2026.

CBG CBD Gummies Market CAGR Analysis by Country and Region

• United States is forecast to expand at 12.2% CAGR from 2026 to 2036. Broad hemp wellness retail and direct brand websites make product education easier for CBG CBD gummies.
• Canada is expected to record 11.4% CAGR through 2036. Licensed edible retail gives tested cannabinoid gummies a more formal route to shoppers.
• From 2026 to 2036, United Kingdom is projected to rise at 9.7% CAGR. Novel food review keeps product entry more controlled, while specialist online retail supports careful CBD and CBG education.
• European Union is anticipated to move ahead at 8.8% CAGR through 2036. Safety review and country-level retail caution keep suppliers focused on product files and dose clarity.
• Australia is likely to advance at 7.9% CAGR from 2026 to 2036. Controlled CBD access limits broad retail activity, but pharmacy-screened routes support cautious buyer education.

Demand Outlook for CBG CBD Gummies Market in the United States

Large hemp wellness retail base · 2026 to 2036

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 82.4 million
Market Forecast in 2036 (Value)	USD 292.2 million
CAGR (2026-2036)	12.2%
Years Considered	2021-2036
Base Year	2025
Forecast Period	2026-2036
Units Considered	Value USD Mn
Leading Sub-Region	National online specialty retail

United States CBG CBD Gummies Market Outlook

United States CBG CBD gummy demand is built around hemp-derived wellness retail and direct brand websites. Shoppers compare dose strength and cannabinoid ratio before adding a new gummy to daily routines.

Retailers prefer products with simple labels and third-party testing. Online brands have an advantage because product pages can explain CBG in plain language before purchase.

Key Growth Drivers

• Hemp flower availability gives extract formulators more room to plan cannabinoid gummy blends. USDA NASS reported 2025 U.S. floral hemp grown in the open at 33.2 million pounds. This gives suppliers a wider input pool for hemp-derived edible products.
• Gummy production control is becoming more important for branded cannabinoid sellers. Charlotte’s Web stated in May 2025 that preliminary in-house commercial gummy production began in Q2 2025. This can improve speed for new blend testing.
• Direct websites help brands explain CBG use and CBD dose without relying only on shelf tags. Clear product pages can reduce buyer confusion before first purchase.
• Routine wellness users are moving toward daytime calm and focus gummies with clear serving instructions. This favors brands that avoid broad health claims and keep labels simple.

Key Restraints

• State-level hemp rules can slow national product rollout for minor cannabinoid gummies.
• Snack-style packs can raise retailer concern because gummy products can look too close to common candy.
• Risky claims can trigger federal review and raise compliance cost. FDA listed seven cannabis-derived product warning letters under its 2025 warning-letter section. This keeps label discipline central for CBG CBD gummy sellers.

What makes United States unique

The United States is unique because hemp wellness retail and direct ecommerce give CBG CBD gummies a broad testing ground.

Key Companies

• Charlotte’s Web Holdings Inc.
• Medterra CBD LLC
• Extract Labs
• CBDfx
• Joy Organics

Sales and Marketing Channels

• Brand-owned ecommerce
• Online specialty retailers
• Wellness retail stores
• Licensed dispensaries
• Subscription programs

Country Segment Breakdown Table

Segment	Sub-Segments
By Cannabinoid Blend	CBD-rich CBG blend · Balanced blend · CBG-rich blend · Broad-spectrum blend · Isolate blend
By Sales Channel	Online specialty retail · Dispensary retail · Pharmacy access · Wellness stores · Direct brand sites
By Dose Range	Low dose · Standard dose · High dose
By Wellness Positioning	Daytime calm · Focus support · Sleep support · Recovery support · General wellness
By Source Status	Hemp-derived · Cannabis-derived
Key Sub-Regions Covered, States	California · Colorado · Florida · Texas · New York · Oregon · Nevada

Frequently Asked Questions

How fast is the United States CBG CBD gummies market growing?

The country snapshot table lists the United States forecast rate through 2036. The pace reflects hemp retail depth and online product comparison.

Who leads the United States CBG CBD gummies market?

Charlotte’s Web Holdings Inc., Medterra CBD LLC, and Extract Labs hold strong positions through brand trust and product documentation.

What is driving adoption of CBG CBD gummies in the United States?

Clear ratio labels and direct ecommerce education are driving adoption. Consumers want to understand CBG before adding it to daily wellness routines.

Demand Outlook for CBG CBD Gummies Market in Canada

Licensed edible retail and controlled access · 2026 to 2036

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 28.3 million
Market Forecast in 2036 (Value)	USD 92.6 million
CAGR (2026-2036)	11.4%
Years Considered	2021-2036
Base Year	2025
Forecast Period	2026-2036
Units Considered	Value USD Mn
Leading Sub-Region	Ontario and British Columbia licensed retail

Canada CBG CBD Gummies Market Outlook

Canada CBG CBD gummies demand runs through licensed edible channels and provincial retail systems. Product entry is more controlled than open wellness ecommerce.

Licensed stores create a different buying path. Staff guidance and compliant labels can help shoppers understand CBG without broad health claims.

Key Growth Drivers

• Edible cannabis has a clear retail place in Canada’s legal market. Health Canada listed edible cannabis at 6,731,962 total medical and non-medical sales units in its latest accessible market table. This gives CBG CBD gummies a tested edible route.
• Branded CBD gummies have entered regulated Canadian retail. Tilray Brands launched Charlotte’s Web CBD gummies in Canada in October 2024. This gives CBG CBD gummies a brand-level benchmark for regulated edible channel activity.
• Provincial distributors can screen product files before gummies reach consumers. This makes compliant packaging and clean testing records more important for suppliers.
• Retail staff can explain cannabinoid ratios to buyers who already understand CBD. This helps CBG products avoid confusion during the buying step.

Key Restraints

• Provincial listing systems can slow product entry for smaller cannabinoid gummy brands.
• Higher retail markups can make CBG CBD gummies harder to price for repeat orders.
• Heavy inventory can make retailers cautious with new edible formats. Health Canada listed edible cannabis packaged inventory at 24,353,645 units in its latest accessible market table. This can slow shelf space for specialty blends.

What makes Canada unique

Canada is unique because licensed retail gives edible cannabinoid products a formal channel with clear package controls.

Key Companies

• Tilray Brands Inc.
• MediPharm Labs Corp.
• Organigram Global Inc.
• Village Farms International Inc.
• Cronos Group Inc.

Sales and Marketing Channels

• Provincial distributors
• Licensed cannabis stores
• Retail staff education
• Brand product pages
• Medical cannabis access routes

Country Segment Breakdown Table

Segment	Sub-Segments
By Cannabinoid Blend	CBD-rich CBG blend · Balanced blend · CBG-rich blend · Broad-spectrum blend · Isolate blend
By Sales Channel	Online specialty retail · Dispensary retail · Pharmacy access · Wellness stores · Direct brand sites
By Dose Range	Low dose · Standard dose · High dose
By Wellness Positioning	Daytime calm · Focus support · Sleep support · Recovery support · General wellness
By Source Status	Hemp-derived · Cannabis-derived
Key Sub-Regions Covered, Provinces	Ontario · British Columbia · Alberta · Quebec · Manitoba · Saskatchewan · Nova Scotia

Frequently Asked Questions

How fast is the Canada CBG CBD gummies market growing?

The country snapshot table lists Canada’s forecast rate through 2036. Licensed edible channels support measured product entry.

Who leads the Canada CBG CBD gummies market?

Tilray Brands Inc., MediPharm Labs Corp., and Organigram Global Inc. are active across regulated cannabinoid access and product supply.

What is driving adoption of CBG CBD gummies in Canada?

Licensed stores and tested edible systems help shoppers trust cannabinoid gummy products. Clear package controls improve buyer comfort.

Sales Analysis of CBG CBD Gummies Market in the United Kingdom

Novel food review and specialist online retail · 2026 to 2036

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 17.2 million
Market Forecast in 2036 (Value)	USD 47.7 million
CAGR (2026-2036)	9.7%
Years Considered	2021-2036
Base Year	2025
Forecast Period	2026-2036
Units Considered	Value USD Mn
Leading Sub-Region	Online wellness retail

United Kingdom CBG CBD Gummies Market Outlook

United Kingdom demand is guided by CBD novel food review and cautious online wellness retail. CBG CBD gummies need simple labels and conservative benefit wording.

Brands with product files and intake guidance have a better route into specialist retail. Buyers need proof that edible cannabinoid products fit current food rules.

Key Growth Drivers

• Consumer familiarity gives CBD gummies a starting point for CBG education. FSA’s June 2025 consumer tracker reported that 11.0% of respondents had used or consumed CBD in the past 6 months. This gives CBG CBD products an existing awareness pool.
• Package guidance is important because buyers often rely on label instructions. FSA’s June 2025 tracker found 54.0% of CBD consumers decided a suitable dose by following packaging or label instructions. This supports clear serving guidance for low-dose gummies.
• Online wellness stores can explain CBG and CBD ratios before purchase. This is useful because CBG is less familiar than CBD.
• Low-dose gummies fit buyers who want cautious first trials. Simple serving guidance can reduce hesitation for new cannabinoid blends.

Key Restraints

• Novel food file costs can block smaller brands from formal retail entry.
• Retailers can reject products if labels make broad health claims.
• Authorisation progress is selective and slow for food products. FSA opened consultation in August 2025 on 3 CBD food product applications. This shows why product files can decide retail access.

What makes United Kingdom unique

The United Kingdom is unique because novel food review directly affects which CBD edible products can stay on sale.

Key Companies

• British Cannabis
• Orange County CBD
• Naturecan Ltd.
• Cannaray Brands Ltd.
• fourfive Ltd.

Sales and Marketing Channels

• Online CBD stores
• Brand websites
• Health and wellness retailers
• Specialist retail marketplaces
• Subscription programs

Country Segment Breakdown Table

Segment	Sub-Segments
By Cannabinoid Blend	CBD-rich CBG blend · Balanced blend · CBG-rich blend · Broad-spectrum blend · Isolate blend
By Sales Channel	Online specialty retail · Dispensary retail · Pharmacy access · Wellness stores · Direct brand sites
By Dose Range	Low dose · Standard dose · High dose
By Wellness Positioning	Daytime calm · Focus support · Sleep support · Recovery support · General wellness
By Source Status	Hemp-derived · Cannabis-derived
Key Sub-Regions Covered, Nations and Retail Areas	England · Scotland · Wales · Northern Ireland · London · Midlands · North West England

Frequently Asked Questions

How fast is the United Kingdom CBG CBD gummies market growing?

The country snapshot table lists the United Kingdom forecast rate through 2036. Novel food review keeps product entry more disciplined.

Who leads the United Kingdom CBG CBD gummies market?

British Cannabis, Orange County CBD, and Naturecan Ltd. are active in CBD product supply and online wellness retail.

What is driving adoption of CBG CBD gummies in the United Kingdom?

Specialist online retail and clearer product files are driving adoption. Buyers need simple dose information before trying cannabinoid blends.

Demand Analysis of CBG CBD Gummies Market in the European Union

Safety review and cross-border retail caution · 2026 to 2036

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 41.6 million
Market Forecast in 2036 (Value)	USD 105.2 million
CAGR (2026-2036)	8.8%
Years Considered	2021-2036
Base Year	2025
Forecast Period	2026-2036
Units Considered	Value USD Mn
Leading Sub-Region	Germany and France compliant retail corridors

European Union CBG CBD Gummies Market Outlook

European Union CBG CBD gummy demand moves through safety review and different national retail practices. Retailers often ask for legal review before carrying cannabinoid edibles.

Countries with stronger CBD retail awareness can test CBG CBD gummies first. Brands must keep dose and ingredient files ready before planning wider rollout.

Key Growth Drivers

• CBD novel food interest is active across the European Union. EFSA stated that the European Commission had received over 200 CBD applications by August 2025. This confirms a wide product-review pipeline.
• Risk review is moving forward for better documented products. EFSA stated that 17 CBD applications were under risk assessment by August 2025. This creates a clearer path for suppliers with stronger safety files.
• Germany and France give suppliers larger wellness retail pools for compliant formats. Stronger CBD awareness can make CBG education easier.
• Cross-border ecommerce can help specialist brands test demand before wider retail entry. Product pages can explain CBG ratio before a retailer takes inventory risk.

Key Restraints

• Different national rules can slow one-product rollouts across several EU markets.
• High-dose formats face tighter review because edible CBD intake is closely examined.
• Safety guidance keeps formulation planning cautious. EFSA set a provisional safe CBD level of 0.0275 mg/kg body weight per day in February 2026. This limits room for higher-dose positioning.

What makes European Union unique

The European Union is unique because CBD edible access is guided by EU-level safety review and country-level retail caution.

Key Companies

• Nordic Oil GmbH
• Enecta S.r.l.
• Endoca BV
• Hanfgeflüster GmbH
• PharmaHemp d.o.o.

Sales and Marketing Channels

• Cross-border ecommerce
• Specialist CBD stores
• Wellness retailers
• Pharmacy-style retail routes
• Distributor platforms

Country Segment Breakdown Table

Segment	Sub-Segments
By Cannabinoid Blend	CBD-rich CBG blend · Balanced blend · CBG-rich blend · Broad-spectrum blend · Isolate blend
By Sales Channel	Online specialty retail · Dispensary retail · Pharmacy access · Wellness stores · Direct brand sites
By Dose Range	Low dose · Standard dose · High dose
By Wellness Positioning	Daytime calm · Focus support · Sleep support · Recovery support · General wellness
By Source Status	Hemp-derived · Cannabis-derived
Key Sub-Regions Covered, Countries	Germany · France · Netherlands · Italy · Spain · Sweden · Denmark

Frequently Asked Questions

How fast is the European Union CBG CBD gummies market growing?

The country snapshot table lists the European Union forecast rate through 2036. Safety review keeps product entry selective.

Who leads the European Union CBG CBD gummies market?

Nordic Oil GmbH, Enecta S.r.l., and Endoca BV hold active positions across CBD retail and online education.

What is driving adoption of CBG CBD gummies in the European Union?

Specialist CBD retail and cross-border ecommerce are driving adoption. Safety files decide which products can move into broader channels.

Opportunity Analysis of CBG CBD Gummies Market in Australia

Controlled CBD access and pharmacy-screened routes · 2026 to 2036

Country Market Snapshot Table

Parameter	Value
Market Size in 2025 (Value)	USD 9.1 million
Market Forecast in 2036 (Value)	USD 21.0 million
CAGR (2026-2036)	7.9%
Years Considered	2021-2036
Base Year	2025
Forecast Period	2026-2036
Units Considered	Value USD Mn
Leading Sub-Region	Pharmacy-screened access routes

Australia CBG CBD Gummies Market Outlook

Australia CBG CBD gummy demand is shaped by controlled CBD access and pharmacy-screened education. Mass wellness retail is harder in Australia than in North America.

Suppliers need legal review and careful product education before presenting edible cannabinoid formats to consumers. Low-dose positioning must fit the country’s health-product lens.

Key Growth Drivers

• Medicinal cannabis access has widened through unapproved medicine pathways. TGA reported 177,762 Special Access Scheme Category B approvals for unapproved medicinal cannabis products in 2024. This shows broader medicinal cannabinoid familiarity among patients and prescribers.
• Registered CBD product records are beginning to appear in sponsor listings. TGA listed CBD 200 LGP PURE under Little Green Pharma Ltd. on 26 November 2024. This shows active CBD product documentation inside official systems.
• Pharmacy-screened guidance can help cautious buyers understand low-dose cannabinoid use. That path suits products needing safety-first explanation.
• Education-based selling can support CBG CBD formats without broad public claims. Suppliers with clean product files should be better placed.

Key Restraints

• Broad retail entry is limited because over-the-counter CBD products face registration hurdles.
• Advertising limits make it harder for brands to explain CBG benefits to new buyers.
• Schedule 3 CBD access has not yet created a broad retail shelf. TGA stated in August 2025 that 0 complete CBD applications meeting Schedule 3 registration requirements had been submitted or evaluated. This keeps consumer gummy access narrow.

What makes Australia unique

Australia is unique because CBG CBD gummy access must pass through a stricter health-product lens than open wellness retail.

Key Companies

• Little Green Pharma Ltd.
• Cannatrek Ltd.
• ECS Botanics Holdings Ltd.
• Tasmanian Botanics Pty Ltd.
• Vitura Health Limited

Sales and Marketing Channels

• Pharmacy guidance
• Medical cannabis clinics
• Practitioner referral routes
• Specialty import channels
• Online product education

Country Segment Breakdown Table

Segment	Sub-Segments
By Cannabinoid Blend	CBD-rich CBG blend · Balanced blend · CBG-rich blend · Broad-spectrum blend · Isolate blend
By Sales Channel	Online specialty retail · Dispensary retail · Pharmacy access · Wellness stores · Direct brand sites
By Dose Range	Low dose · Standard dose · High dose
By Wellness Positioning	Daytime calm · Focus support · Sleep support · Recovery support · General wellness
By Source Status	Hemp-derived · Cannabis-derived
Key Sub-Regions Covered, States	New South Wales · Victoria · Queensland · Western Australia · South Australia · Tasmania · Australian Capital Territory

Frequently Asked Questions

How fast is the Australia CBG CBD gummies market growing?

The country snapshot table lists Australia’s forecast rate through 2036. Access stays more controlled than in open wellness channels.

Who leads the Australia CBG CBD gummies market?

Little Green Pharma Ltd., Cannatrek Ltd., and ECS Botanics Holdings Ltd. are active across regulated cannabinoid supply.

What is driving adoption of CBG CBD gummies in Australia?

Pharmacy-screened education and medical cannabis infrastructure are driving cautious adoption. Suppliers need stronger legal review before wider retail entry.

Competitive Landscape and Strategic Positioning

• Established CBD gummy brands hold an advantage based on consumer trust and tested hemp source files.
• Minor cannabinoid specialists support CBG CBD gummy work with ratio-based labels and lab-backed product pages.
• Online channel builders improve customer access through direct websites and clear product education.
• Licensed cannabis partners support regulated access in Canada and Australia through controlled retail routes.

CBG CBD gummy market competition is centered on trust and clear product explanation. Retailers assess suppliers based on cannabinoid testing and label discipline before accepting gummies into wellness channels. Consumers compare CBG ratio and CBD dose before buying a product for daily use. Brands connected with CBD gummies need simple product pages because shoppers often learn the difference between CBD and CBG during the buying step.

Competitive structure is led by established CBD brands and minor cannabinoid formulators. Charlotte’s Web supports the market through branded CBD and CBG wellness products. Medterra supports retail access through CBD gummy formats and consumer education. Extract Labs and Neurogan add strength through broader minor cannabinoid product depth. CBDfx and Joy Organics support online sales with clear product pages and direct customer access. Nordic Oil and Cibdol support European CBD retail through compliance-focused online channels.

Supplier advantage is expected to come from dose accuracy and clean documentation. Larger brands are better placed to secure specialist retail accounts because they can provide certificates and product files faster. Smaller formulators can protect their position if they offer custom ratios and reliable gummy quality. Companies with adult-oriented packaging and clear hemp source records should secure repeat demand across wellness retail and online cannabinoid comparison channels.

Key Companies in CBG CBD Gummies Market

• Brand Owners: Charlotte’s Web and Medterra support consumer-facing CBG CBD gummy awareness through branded wellness products and direct online channels.
• Minor Cannabinoid Specialists: Extract Labs and Neurogan support CBG blend products with ratio-based education and lab-backed product pages.
• Regulated and Regional Channel Players: Tilray Brands, MediPharm Labs, Nordic Oil, and Cibdol support regulated access or specialist CBD retail in Canada, Australia, and European countries.

Company Benchmarking Table

Company	CBG Blend File Strength	Gummy Product Control	Compliant Channel Reach
Charlotte’s Web	High	High	High
Medterra	High	Medium	High
Extract Labs	High	High	Medium
CBDfx	Medium	Medium	Medium
Joy Organics	Medium	Medium	High
Neurogan	High	Medium	Medium
Nordic Oil	Medium	Medium	Medium

Recent Industry Developments

• In August 2025, Charlotte’s Web reported CBG Focus & Attention Gummies within its wellness product range. The launch supports demand for CBG CBD gummy formats built around daytime use and clear blend positioning.
• In October 2024, Tilray Brands launched Charlotte’s Web CBD gummies in Canada. The launch supported regulated access for branded CBD gummy formats in a market with licensed edible channels.

Key Players in the CBG CBD Gummies Market

• Charlotte’s Web Holdings Inc.
• Medterra CBD LLC
• Extract Labs
• CBDfx
• Joy Organics
• Neurogan
• Koi CBD
• Tilray Brands Inc.
• Nordic Oil GmbH
• Cibdol

CBG CBD Gummies Market - Report Scope

Parameter	Details
Market size by 2036	USD 585.5 million
Growth rate	10.8% CAGR from 2026 to 2036
Forecast period	2026 to 2036
Base year value in 2025	USD 189.5 million
By cannabinoid blend	CBD-rich CBG blend, balanced blend, CBG-rich blend, broad-spectrum blend, isolate blend
By dose range	Low dose, standard dose, high dose
By wellness positioning	Daytime calm, focus support, sleep support, recovery support, general wellness
By sales channel	Online specialty retail, dispensary retail, pharmacy access, wellness stores, direct brand sites
By source status	Hemp-derived, cannabis-derived
Regions covered	North America, Europe, Oceania
Countries and regions covered	United States, Canada, United Kingdom, European Union, Australia
Key companies profiled	Charlotte’s Web Holdings Inc., Medterra CBD LLC, Extract Labs, CBDfx, Joy Organics, Neurogan, Koi CBD, Tilray Brands Inc., Nordic Oil GmbH, Cibdol
Approach	Bottom-up product-boundary approach using eligible SKU revenue, channel presence, retail pricing, product positioning, and country-level adoption

Source: Future Market Insights, 2026.

CBG CBD Gummies Market Breakdown by Cannabinoid Blend, Dose Range, Wellness Positioning, Sales Channel, Source Status, and Region

By Cannabinoid Blend:

• CBD-Rich CBG Blend
• Balanced Blend
• CBG-Rich Blend
• Broad-Spectrum Blend
• Isolate Blend

By Dose Range:

• Low Dose
• Standard Dose
• High Dose

By Wellness Positioning:

• Daytime Calm
• Focus Support
• Sleep Support
• Recovery Support
• General Wellness

By Sales Channel:

• Online Specialty Retail
• Dispensary Retail
• Pharmacy Access
• Wellness Stores
• Direct Brand Sites

By Source Status:

• Hemp-Derived
• Cannabis-Derived

By Region:

• North America
• Europe
• Oceania

By Country and Region:

• United States
• Canada
• United Kingdom
• European Union
• Australia

This Report Answers

• How large is CBG CBD gummies market in 2026?
• What value is expected for CBG CBD gummies market by 2036?
• Which source status is expected to hold a strong share in 2026?
• Which cannabinoid blend is expected to hold a strong share in 2026?
• Which sales channel is expected to hold a strong share in 2026?
• Which countries and regions are expected to move faster than the global average?
• Which companies are active across CBG CBD gummy supply?
• Which regulatory issues affect edible cannabinoid product planning?
• Which product positions create repeat demand for CBG CBD gummies?

Research Sources and Bibliography

• Charlotte’s Web Holdings, Inc. (2025, May 14). Charlotte’s Web reports year-over-year growth for Q1 2025. Charlotte’s Web Holdings, Inc.
• Charlotte’s Web Holdings, Inc. (2025, August 13). Charlotte’s Web reports year-over-year growth for Q2 2025. Charlotte’s Web Holdings, Inc.
• DoorDash. (2025, January 9). DoorDash expands offerings to include hemp-derived products in select states. DoorDash.
• European Food Safety Authority. (2026, February 9). Update of the statement on safety of cannabidiol as a novel food. EFSA Journal.
• Federal Trade Commission. (2024, July 16). FTC and FDA send second set of cease-and-desist letters to companies selling products containing delta-8 THC in packaging designed to look like children’s snacks. Federal Trade Commission.
• Food Standards Agency. (2025, July 30). Consumer Insights Tracker: April 2025–June 2025. Food Standards Agency.
• Food Standards Agency. (2025, August 28). Consultation on applications for authorisation of 3 Cannabidiol (CBD) food products as novel foods August 2025. Food Standards Agency.
• Health Canada. (2026, March 6). Canadian Cannabis Survey 2024: Summary. Government of Canada.
• Health Canada. (2026, May 15). Cannabis market data. Government of Canada.
• Therapeutic Goods Administration. (2024, November 26). CBD 200 LGP PURE (470485). Australian Government Department of Health, Disability and Ageing.
• Therapeutic Goods Administration. (2025, August). Reviewing the safety and regulatory oversight of unapproved medicinal cannabis products. Australian Government Department of Health, Disability and Ageing.
• Tilray Brands, Inc. (2024, October 7). Tilray Brands launches Charlotte’s Web CBD gummies in Canada. Tilray Brands, Inc.
• U.S. Department of Agriculture, National Agricultural Statistics Service. (2026, April 16). National Hemp Report. U.S. Department of Agriculture.
• U.S. Food and Drug Administration. (2024, August 30). Root Bioscience Brands, LLC dba Naternal - 673646 - 08/30/2024. U.S. Food and Drug Administration.
• U.S. Food and Drug Administration. (2025, September 3). Warning letters for cannabis-derived products. U.S. Food and Drug Administration.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations